scispace - formally typeset
G

Gerd-Rüdiger Burmester

Researcher at Humboldt University of Berlin

Publications -  237
Citations -  16129

Gerd-Rüdiger Burmester is an academic researcher from Humboldt University of Berlin. The author has contributed to research in topics: Arthritis & Rheumatoid arthritis. The author has an hindex of 57, co-authored 231 publications receiving 14887 citations. Previous affiliations of Gerd-Rüdiger Burmester include Leibniz Association & Free University of Berlin.

Papers
More filters
Journal ArticleDOI

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

TL;DR: In this article, the authors present a set of recommendations for the treatment of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs (DMARDs) and glucocorticoids (GCs) that also account for strategic algorithms and deal with economic aspects.
Journal ArticleDOI

Guidelines for musculoskeletal ultrasound in rheumatology

TL;DR: US is most commonly used in the assessment of soft tissue disease or detection of fluid collection and can also be used to visualise other structures, such as cartilage and bone surfaces, and its ability to be repeated as often as necessary makes it particularly useful for the monitoring of treatment.
Journal ArticleDOI

Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging.

TL;DR: MRI and ultrasound are valuable diagnostic methods in patients with arthritis who have normal findings on radiologic evaluation and found ultrasound to be even more sensitive than MRI in the detection of synovitis.
Journal ArticleDOI

Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.

TL;DR: Results from this large, placebo-controlled safety study demonstrate that anakinra is safe and well tolerated in a diverse population of patients with RA, including those with comorbid conditions and those using multiple combinations of concomitant therapies.